Matches in Wikidata for { <http://www.wikidata.org/entity/Q62030742> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q62030742 description "clinical trial" @default.
- Q62030742 description "ensayo clínico" @default.
- Q62030742 description "ensayu clínicu" @default.
- Q62030742 description "klinisch onderzoek" @default.
- Q62030742 description "клінічне випробування" @default.
- Q62030742 description "临床试验" @default.
- Q62030742 name "An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis" @default.
- Q62030742 type Item @default.
- Q62030742 label "An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis" @default.
- Q62030742 prefLabel "An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis" @default.
- Q62030742 P1050 Q62030742-9043FC4D-69F6-4B3E-8A2D-9D208E7DF027 @default.
- Q62030742 P1132 Q62030742-E0AF4D8E-CF8D-4117-B76B-79F37DE0C377 @default.
- Q62030742 P1476 Q62030742-8304DD8E-E000-403E-B647-7CA57A3328B9 @default.
- Q62030742 P1813 Q62030742-F6500C7B-4859-401A-ABB9-D529719DD623 @default.
- Q62030742 P2899 Q62030742-3E3A530A-2390-4EE9-ACAD-C187B2AA65C7 @default.
- Q62030742 P3098 Q62030742-3CE6AFCE-5C45-4308-BFF3-47D8DE56FCAA @default.
- Q62030742 P31 Q62030742-81752F4B-E2B9-4B16-BD90-CFB431CA3A62 @default.
- Q62030742 P4844 Q62030742-4B40AE7F-24DC-4DB0-86B2-796BD16D6B42 @default.
- Q62030742 P4844 Q62030742-5972D3EF-0F1C-4355-86B5-15A3B9C83D6F @default.
- Q62030742 P580 Q62030742-DF0F146E-1929-4B60-B068-85BD90BB0FC3 @default.
- Q62030742 P582 Q62030742-4E97FFC8-2295-45C6-B6BE-3B28BCB1A1F4 @default.
- Q62030742 P6099 Q62030742-AB25E46D-10EA-4400-BA49-9C5F13279249 @default.
- Q62030742 P6153 Q62030742-22928F79-AD12-4D86-A4E9-A05DD7E36472 @default.
- Q62030742 P6153 Q62030742-C8B79075-429E-4852-8FF3-58BF10C5999F @default.
- Q62030742 P6153 Q62030742-E85B564F-61C1-4432-A56C-8FB44B8CAD9B @default.
- Q62030742 P6153 Q62030742-EA357C9A-97D8-4E7C-9C66-0E26BB3B49CD @default.
- Q62030742 P8005 Q62030742-998B44D9-F20A-4CBF-886B-664BB2BC4569 @default.
- Q62030742 P8363 Q62030742-8EAD3A10-CA09-4872-87F1-AE44A9A253D3 @default.
- Q62030742 P859 Q62030742-DF03A3F2-B569-4149-A991-EC78D7EE0C25 @default.
- Q62030742 P1050 Q179945 @default.
- Q62030742 P1132 "+332" @default.
- Q62030742 P1476 "A Phase 3, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis" @default.
- Q62030742 P1813 "DISCREET" @default.
- Q62030742 P2899 "+18" @default.
- Q62030742 P3098 "NCT03777436" @default.
- Q62030742 P31 Q30612 @default.
- Q62030742 P4844 Q203174 @default.
- Q62030742 P4844 Q2858961 @default.
- Q62030742 P580 "2019-02-19T00:00:00Z" @default.
- Q62030742 P582 "2020-08-24T00:00:00Z" @default.
- Q62030742 P6099 Q42824827 @default.
- Q62030742 P6153 Q1472663 @default.
- Q62030742 P6153 Q2496385 @default.
- Q62030742 P6153 Q2900977 @default.
- Q62030742 P6153 Q833670 @default.
- Q62030742 P8005 Q76649708 @default.
- Q62030742 P8363 Q78089383 @default.
- Q62030742 P859 Q842947 @default.